(-)-epigallocatechin 3-gallate increases expression ISO RGD:1314553 6480464 epigallocatechin gallate results in increased expression of GLI3 mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1314553 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GLI3 mRNA CTD PMID:22079256 1,2-dimethylhydrazine increases expression ISO RGD:1314554 6480464 1, 2-Dimethylhydrazine results in increased expression of GLI3 mRNA CTD PMID:22206623 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GLI3 mRNA CTD PMID:15328011 17beta-estradiol increases expression ISO RGD:1314554 6480464 Estradiol results in increased expression of GLI3 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:1314553 6480464 Estradiol results in increased expression of GLI3 mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314554 6480464 Tetrachlorodibenzodioxin affects the expression of GLI3 mRNA CTD PMID:21570461 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GLI3 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-hydroxypropanoic acid increases expression ISO RGD:1314553 6480464 Lactic Acid results in increased expression of GLI3 mRNA CTD PMID:30851411 Ac-Ser-Asp-Lys-Pro-OH multiple interactions EXP 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein], goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein] CTD PMID:31181250 Ac-Ser-Asp-Lys-Pro-OH multiple interactions ISO RGD:1314553 6480464 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in decreased expression of GLI3 protein], goralatide inhibits the reaction [AGT protein results in decreased expression of GLI3 protein] CTD PMID:31181250 aflatoxin B1 decreases methylation ISO RGD:1314553 6480464 Aflatoxin B1 results in decreased methylation of GLI3 intron CTD PMID:30157460 aflatoxin B1 increases methylation ISO RGD:1314553 6480464 Aflatoxin B1 results in increased methylation of GLI3 gene CTD PMID:27153756 antimycin A decreases expression ISO RGD:1314553 6480464 Antimycin A results in decreased expression of GLI3 mRNA CTD PMID:33512557 antirheumatic drug increases expression ISO RGD:1314553 6480464 Antirheumatic Agents results in increased expression of GLI3 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1314553 6480464 aristolochic acid I results in decreased expression of GLI3 mRNA CTD PMID:33212167 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of GLI3 mRNA CTD PMID:34858468 arsane affects methylation ISO RGD:1314553 6480464 Arsenic affects the methylation of GLI3 gene CTD PMID:25304211 arsane decreases expression ISO RGD:1314553 6480464 Arsenic results in decreased expression of GLI3 mRNA CTD PMID:31739468 arsane multiple interactions ISO RGD:1314553 6480464 [Arsenic co-treated with Iron] results in decreased expression of GLI3 mRNA CTD PMID:31739468 arsane affects expression ISO RGD:1314553 6480464 Arsenic affects the expression of GLI3 mRNA CTD PMID:28615018 arsenic atom affects methylation ISO RGD:1314553 6480464 Arsenic affects the methylation of GLI3 gene CTD PMID:25304211 arsenic atom decreases expression ISO RGD:1314553 6480464 Arsenic results in decreased expression of GLI3 mRNA CTD PMID:31739468 arsenic atom multiple interactions ISO RGD:1314553 6480464 [Arsenic co-treated with Iron] results in decreased expression of GLI3 mRNA CTD PMID:31739468 arsenic atom affects expression ISO RGD:1314553 6480464 Arsenic affects the expression of GLI3 mRNA CTD PMID:28615018 arsenous acid multiple interactions ISO RGD:1314553 6480464 Arsenic Trioxide promotes the reaction [[GLI3 protein binds to KIT promoter] which results in decreased expression of KIT mRNA], Arsenic Trioxide promotes the reaction [GLI3 protein binds to KIT promoter] CTD PMID:27793025 atrazine decreases expression ISO RGD:1314554 6480464 Atrazine results in decreased expression of GLI3 mRNA CTD PMID:33463082 azoxystrobin decreases expression ISO RGD:1314553 6480464 azoxystrobin results in decreased expression of GLI3 mRNA CTD PMID:33512557 benzo[a]pyrene affects expression ISO RGD:1314553 6480464 Benzo(a)pyrene affects the expression of GLI3 mRNA CTD PMID:21714911 benzo[a]pyrene increases expression ISO RGD:1314553 6480464 Benzo(a)pyrene results in increased expression of GLI3 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1314553 6480464 Benzo(a)pyrene affects the methylation of GLI3 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1314554 6480464 Benzo(a)pyrene results in increased methylation of GLI3 exon, Benzo(a)pyrene results in increased methylation of GLI3 intron CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1314553 6480464 Benzo(a)pyrene results in decreased methylation of GLI3 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1314553 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GLI3 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:1314553 6480464 bisphenol A results in decreased methylation of GLI3 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GLI3 mRNA CTD PMID:34858468 bisphenol A decreases expression ISO RGD:1314553 6480464 bisphenol A results in decreased expression of GLI3 mRNA CTD PMID:28238728 bisphenol A multiple interactions ISO RGD:1314553 6480464 MIR107 mRNA promotes the reaction [bisphenol A results in decreased expression of GLI3 mRNA] CTD PMID:28238728 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of GLI3 mRNA CTD PMID:32479839 cadmium atom multiple interactions ISO RGD:1314553 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GLI3 mRNA CTD PMID:35301059 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GLI3 mRNA CTD PMID:33453195 cadmium dichloride multiple interactions ISO RGD:1314553 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GLI3 mRNA CTD PMID:35301059 caffeine increases phosphorylation ISO RGD:1314553 6480464 Caffeine results in increased phosphorylation of GLI3 protein CTD PMID:35688186 captopril multiple interactions EXP 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein], Captopril inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein] CTD PMID:31181250 captopril multiple interactions ISO RGD:1314553 6480464 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in decreased expression of GLI3 protein] CTD PMID:31181250 carbon nanotube increases expression ISO RGD:1314554 6480464 Nanotubes, Carbon results in increased expression of GLI3 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1314553 6480464 CGP 52608 promotes the reaction [RORA protein binds to GLI3 gene] CTD PMID:28238834 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of GLI3 mRNA CTD PMID:34858468 choline multiple interactions ISO RGD:1314554 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLI3 mRNA CTD PMID:20938992 chromium(6+) decreases expression ISO RGD:1314553 6480464 chromium hexavalent ion results in decreased expression of GLI3 mRNA CTD PMID:30690063 cisplatin decreases expression ISO RGD:1314553 6480464 Cisplatin results in decreased expression of GLI3 mRNA CTD PMID:19561079 , PMID:21603599 copper atom multiple interactions ISO RGD:1314553 6480464 [NSC 689534 binds to Copper] which results in decreased expression of GLI3 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1314553 6480464 [NSC 689534 binds to Copper] which results in decreased expression of GLI3 mRNA CTD PMID:20971185 cyclosporin A increases expression ISO RGD:1314553 6480464 Cyclosporine results in increased expression of GLI3 mRNA CTD PMID:33631201 deguelin decreases expression ISO RGD:1314553 6480464 deguelin results in decreased expression of GLI3 mRNA CTD PMID:33512557 dextran sulfate multiple interactions ISO RGD:1314554 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GLI3 mRNA CTD PMID:29950665 diarsenic trioxide multiple interactions ISO RGD:1314553 6480464 Arsenic Trioxide promotes the reaction [[GLI3 protein binds to KIT promoter] which results in decreased expression of KIT mRNA], Arsenic Trioxide promotes the reaction [GLI3 protein binds to KIT promoter] CTD PMID:27793025 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of GLI3 mRNA CTD PMID:25213187 , PMID:27079746 dorsomorphin multiple interactions ISO RGD:1314553 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLI3 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:1314554 6480464 epoxiconazole results in decreased expression of GLI3 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:1314554 6480464 Ethanol results in increased expression of GLI3 mRNA CTD PMID:30319688 ethanol increases cleavage ISO RGD:1314554 6480464 Ethanol results in increased cleavage of GLI3 protein CTD PMID:34492310 ethanol affects expression ISO RGD:1314554 6480464 Ethanol affects the expression of GLI3 mRNA CTD PMID:30319688 fenpyroximate decreases expression ISO RGD:1314553 6480464 fenpyroximate results in decreased expression of GLI3 mRNA CTD PMID:33512557 folic acid multiple interactions ISO RGD:1314554 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLI3 mRNA, Folic Acid inhibits the reaction [[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA] CTD PMID:17688467 , PMID:20938992 folic acid decreases expression ISO RGD:1314554 6480464 Folic Acid results in decreased expression of GLI3 mRNA CTD PMID:25629700 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of GLI3 mRNA CTD PMID:22061828 goralatide multiple interactions ISO RGD:1314553 6480464 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in decreased expression of GLI3 protein], goralatide inhibits the reaction [AGT protein results in decreased expression of GLI3 protein] CTD PMID:31181250 goralatide multiple interactions EXP 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein], goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein] CTD PMID:31181250 iron atom multiple interactions ISO RGD:1314553 6480464 [Arsenic co-treated with Iron] results in decreased expression of GLI3 mRNA CTD PMID:31739468 iron(0) multiple interactions ISO RGD:1314553 6480464 [Arsenic co-treated with Iron] results in decreased expression of GLI3 mRNA CTD PMID:31739468 L-methionine multiple interactions ISO RGD:1314554 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLI3 mRNA CTD PMID:20938992 melphalan decreases expression ISO RGD:1314553 6480464 Melphalan results in decreased expression of GLI3 mRNA CTD PMID:22363485 methimazole increases expression EXP 6480464 Methimazole results in increased expression of GLI3 mRNA CTD PMID:25539664 methylmercury chloride decreases expression ISO RGD:1314553 6480464 methylmercuric chloride results in decreased expression of GLI3 mRNA CTD PMID:28001369 miconazole increases expression ISO RGD:1314554 6480464 Miconazole results in increased expression of GLI3 mRNA CTD PMID:27462272 mono(2-ethylhexyl) phthalate affects expression ISO RGD:1314553 6480464 mono-(2-ethylhexyl)phthalate affects the expression of GLI3 mRNA CTD PMID:26710974 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:1314554 6480464 Ethylnitrosourea results in increased mutagenesis of GLI3 gene CTD PMID:18397875 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of GLI3 mRNA CTD PMID:28801915 ochratoxin A multiple interactions ISO RGD:1314554 6480464 [GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA more ... CTD PMID:16922921 , PMID:17688467 ochratoxin A increases response to substance ISO RGD:1314554 6480464 GLI3 gene mutant form results in increased susceptibility to ochratoxin A CTD PMID:16922921 , PMID:17688467 ochratoxin A affects response to substance ISO RGD:1314554 6480464 GLI3 gene affects the susceptibility to ochratoxin A CTD PMID:20201966 paracetamol increases expression ISO RGD:1314553 6480464 Acetaminophen results in increased expression of GLI3 mRNA CTD PMID:26690555 phenylmercury acetate multiple interactions ISO RGD:1314553 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLI3 mRNA CTD PMID:27188386 picoxystrobin decreases expression ISO RGD:1314553 6480464 picoxystrobin results in decreased expression of GLI3 mRNA CTD PMID:33512557 potassium chromate multiple interactions ISO RGD:1314553 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GLI3 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1314553 6480464 potassium chromate(VI) results in decreased expression of GLI3 mRNA CTD PMID:22079256 , PMID:22714537 Ptaquiloside decreases expression ISO RGD:1314554 6480464 ptaquiloside results in decreased expression of GLI3 mRNA CTD PMID:23274088 pyrimidifen decreases expression ISO RGD:1314553 6480464 pyrimidifen results in decreased expression of GLI3 mRNA CTD PMID:33512557 rac-lactic acid increases expression ISO RGD:1314553 6480464 Lactic Acid results in increased expression of GLI3 mRNA CTD PMID:30851411 rotenone decreases expression ISO RGD:1314553 6480464 Rotenone results in decreased expression of GLI3 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1314553 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLI3 mRNA CTD PMID:27188386 silicon dioxide multiple interactions EXP 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein] more ... CTD PMID:31181250 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of GLI3 protein CTD PMID:31181250 sodium arsenite increases expression ISO RGD:1314554 6480464 sodium arsenite results in increased expression of GLI3 mRNA CTD PMID:20179202 succimer multiple interactions ISO RGD:1314553 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GLI3 mRNA CTD PMID:26378955 succimer multiple interactions ISO RGD:1314554 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLI3 mRNA CTD PMID:26378955 sunitinib decreases expression ISO RGD:1314553 6480464 Sunitinib results in decreased expression of GLI3 mRNA CTD PMID:31533062 titanium dioxide multiple interactions ISO RGD:1314554 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GLI3 mRNA CTD PMID:29950665 trichostatin A decreases expression ISO RGD:1314553 6480464 trichostatin A results in decreased expression of GLI3 mRNA CTD PMID:22723015 , PMID:24935251 trichostatin A increases expression ISO RGD:1314553 6480464 trichostatin A results in increased expression of GLI3 mRNA CTD PMID:24935251 valproic acid increases response to substance ISO RGD:1314554 6480464 GLI3 gene mutant form results in increased susceptibility to Valproic Acid CTD PMID:16359493 valproic acid affects expression ISO RGD:1314553 6480464 Valproic Acid affects the expression of GLI3 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1314553 6480464 Valproic Acid results in increased expression of GLI3 mRNA CTD PMID:24935251 , PMID:28001369 valproic acid decreases methylation ISO RGD:1314553 6480464 Valproic Acid results in decreased methylation of GLI3 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1314554 6480464 Valproic Acid promotes the reaction [GLI3 gene mutant form affects the expression of FGF8 mRNA] CTD PMID:16359493 valproic acid decreases response to substance ISO RGD:1314554 6480464 GLI3 protein results in decreased susceptibility to Valproic Acid CTD PMID:16359493 vismodegib multiple interactions ISO RGD:1314553 6480464 HhAntag691 inhibits the reaction [AGT protein results in decreased expression of GLI3 protein] CTD PMID:31181250 zinc oxide increases expression ISO RGD:1314554 6480464 Zinc Oxide results in increased expression of GLI3 mRNA CTD PMID:33236829
